- Home
- XMTR vs XENE Comparison
XMTR vs XENE Comparison
Compare XMTR & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XMTR
- XENE
- Stock Information
- Founded
- XMTR 2013
- XENE 1996
- Country
- XMTR United States
- XENE Canada
- Employees
- XMTR N/A
- XENE N/A
- Industry
- XMTR Industrial Machinery/Components
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- XMTR Technology
- XENE Health Care
- Exchange
- XMTR Nasdaq
- XENE Nasdaq
- Market Cap
- XMTR 2.4B
- XENE 2.4B
- IPO Year
- XMTR 2021
- XENE 2014
- Fundamental
- Price
- XMTR $49.68
- XENE $39.21
- Analyst Decision
- XMTR Buy
- XENE Strong Buy
- Analyst Count
- XMTR 11
- XENE 11
- Target Price
- XMTR $37.00
- XENE $52.73
- AVG Volume (30 Days)
- XMTR 750.5K
- XENE 833.8K
- Earning Date
- XMTR 11-04-2025
- XENE 08-11-2025
- Dividend Yield
- XMTR N/A
- XENE N/A
- EPS Growth
- XMTR N/A
- XENE N/A
- EPS
- XMTR N/A
- XENE N/A
- Revenue
- XMTR $603,762,000.00
- XENE $7,500,000.00
- Revenue This Year
- XMTR $22.43
- XENE N/A
- Revenue Next Year
- XMTR $17.51
- XENE $256.34
- P/E Ratio
- XMTR N/A
- XENE N/A
- Revenue Growth
- XMTR 20.19
- XENE N/A
- 52 Week Low
- XMTR $16.11
- XENE $26.74
- 52 Week High
- XMTR $51.68
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- XMTR 61.19
- XENE 67.80
- Support Level
- XMTR $45.62
- XENE $38.13
- Resistance Level
- XMTR $51.68
- XENE $39.84
- Average True Range (ATR)
- XMTR 2.60
- XENE 0.99
- MACD
- XMTR -0.26
- XENE -0.09
- Stochastic Oscillator
- XMTR 75.53
- XENE 77.70
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.